BLUE Bluebird Bio Inc

bluebird bio Inc is a clinical-stage biotechnology company which develops gene therapies for severe genetic and rare diseases and in the field of T cell-based immunotherapy.

$4.27  +0.13 (3.14%)
As of 07/01/2022 15:59:51 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/19/2013
Outstanding shares:  71,453,733
Average volume:  15,228,700
Market cap:   $295,818,455
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BBFL7S1
Valuation   (See tab for details)
PE ratio:   -0.42
PB ratio:   1.16
PS ratio:   -41.16
Return on equity:   -279.47%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy